-
Reply to S. Zhang et al and S. Selukar J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-24 Nathaniel S. O'Connell
Journal of Clinical Oncology, Ahead of Print.
-
Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-23 Cindy Im, Achal Neupane, Jessica L. Baedke, Brian Lenny, Angela Delaney, Stephanie B. Dixon, Eric J. Chow, Sogol Mostoufi-Moab, Tianzhong Yang, Melissa A. Richard, M. Monica Gramatges, Philip J. Lupo, Noha Sharafeldin, Smita Bhatia, Gregory T. Armstrong, Melissa M. Hudson, Kirsten K. Ness, Leslie L. Robison, Yutaka Yasui, Carmen L. Wilson, Yadav Sapkota
Journal of Clinical Oncology, Ahead of Print.
-
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-23 Aditya Bardia, Ian E. Krop, Takahiro Kogawa, Dejan Juric, Anthony W. Tolcher, Erika P. Hamilton, Toru Mukohara, Aaron Lisberg, Toshio Shimizu, Alexander I. Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P. Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam
Journal of Clinical Oncology, Ahead of Print.
-
Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-23 Christian Ekanger, Svein Inge Helle, Lars Reisæter, Liv Bolstad Hysing, Rune Kvåle, Alfred Honoré, Karsten Gravdal, Sara Pilskog, Olav Dahl
Journal of Clinical Oncology, Ahead of Print.
-
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-19 Robert S. Fichtinger, Luca A. Aldrighetti, Mohammed Abu Hilal, Roberto I. Troisi, Robert P. Sutcliffe, Marc G. Besselink, Somaiah Aroori, Krishna V. Menon, Bjørn Edwin, Mathieu D'Hondt, Valerio Lucidi, Tom F. Ulmer, Rafael Díaz-Nieto, Zahir Soonawalla, Steve White, Gregory Sergeant, Bram Olij, Francesca Ratti, Christoph Kuemmerli, Vincenzo Scuderi, Frederik Berrevoet, Aude Vanlander, Ravi Marudanayagam
Journal of Clinical Oncology, Ahead of Print.
-
Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-12 Nicholas Mikolajewicz, Patricia P. Yee, Debarati Bhanja, Mara Trifoi, Alexandra M. Miller, Philippe Metellus, Stephen J. Bagley, Leonora Balaj, Leonardo J.M. de Macedo Filho, Brad E. Zacharia, Dawit Aregawi, Michael Glantz, Michael Weller, Manmeet S. Ahluwalia, Thomas Kislinger, Alireza Mansouri
Journal of Clinical Oncology, Ahead of Print.
-
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-11 Anne Tierens, Nira Arad-Cohen, Daniel Cheuk, Barbara De Moerloose, Jose Maria Fernandez Navarro, Henrik Hasle, Kirsi Jahnukainen, Kristian Løvvik Juul-Dam, Gertjan Kaspers, Zanna Kovalova, Birgitte Lausen, Ulrika Norén-Nyström, Josefine Palle, Ramune Pasauliene, Cornelis Jan Pronk, Kadri Saks, Bernward Zeller, Jonas Abrahamsson
Journal of Clinical Oncology, Ahead of Print.
-
H10: Long-Term Results Could Be Misleading Without an Updated Reading Key for Positron Emission Tomography J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-09 Theodoros P. Vassilakopoulos, Athanasios Liaskas, Patricio Pereyra, Andrea Gallamini
Journal of Clinical Oncology, Ahead of Print.
-
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-09 Alejandro Ríos-Hoyo, Erin Cobain, Laura A. Huppert, Peter D. Beitsch, Thomas A. Buchholz, Laura Esserman, Laura J. van 't Veer, Hope S. Rugo, Lajos Pusztai
Journal of Clinical Oncology, Ahead of Print.
-
Prevalence and Cancer-Specific Patterns of Functional Disability Among US Cancer Survivors, 2017-2022 J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-04 Chao Cao, Lin Yang, Kathryn H. Schmitz, Jennifer A. Ligibel
Journal of Clinical Oncology, Ahead of Print.
-
National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data J. Clin. Oncol. (IF 45.3) Pub Date : 2024-04-02 Joseph M. Unger, Lawrence N. Shulman, Matthew A. Facktor, Heidi Nelson, Mark E. Fleury
Journal of Clinical Oncology, Ahead of Print.
-
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-28 Lihua E. Budde, Sarit Assouline, Laurie H. Sehn, Stephen J. Schuster, Sung-Soo Yoon, Dok Hyun Yoon, Matthew J. Matasar, Francesc Bosch, Won Seog Kim, Loretta J. Nastoupil, Ian W. Flinn, Mazyar Shadman, Catherine Diefenbach, Chan Yoon Cheah, Connie Y. Ma, Huang Huang, Antonia Kwan, Michael C. Wei, Shen Yin, Nancy L. Bartlett
Journal of Clinical Oncology, Ahead of Print.
-
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-28 Claire Gallois, Qian Shi, Levi D. Pederson, Thierry André, Timothy J. Iveson, Alberto F. Sobrero, Steven Alberts, Aimery de Gramont, Jeffrey A. Meyerhardt, Thomas George, Hans-Joachim E. Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A. Sinicrope, Eiji Oki, Anthony F. Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M. Goldberg, Julien
Journal of Clinical Oncology, Ahead of Print.
-
Toward Racial Equity in Lung Cancer Screening Eligibility J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-27 Hasmeena Kathuria, Renda Soylemez Wiener
Journal of Clinical Oncology, Ahead of Print.
-
Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-27 Alexandra L. Potter, Nuo N. Xu, Priyanka Senthil, Deepti Srinivasan, Hang Lee, G. Scott Gazelle, Lydia Chelala, Wei Zheng, Florian J. Fintelmann, Lecia V. Sequist, Jessica Donington, Julie R. Palmer, Chi-Fu Jeffrey Yang
Journal of Clinical Oncology, Ahead of Print.
-
Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022 J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-27 Hong Xiao, Riha Vaidya, Dawn L. Hershman, Joseph M. Unger
Journal of Clinical Oncology, Ahead of Print.
-
Knuckleheads J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-26 Timothy D. Gilligan
Journal of Clinical Oncology, Ahead of Print.
-
International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-26 Michael Sargent Binkley, Jamie E. Flerlage, Kerry J. Savage, Saad Akhtar, Raphael Steiner, Xiao-Yin Zhang, Michael Dickinson, Anca Prica, Ajay Major, Peter G. Hendrickson, David Hopkins, Andrea Ng, Carla Casulo, Jonathan Baron, Kenneth B. Roberts, Jalila Al Kendi, Alex Balogh, Umberto Ricardi, Pallawi Torka, Lena Specht, Ravindu De Silva, Keir Pickard, Lindsay J Blazin, Michael Henry, Christine M.
Journal of Clinical Oncology, Ahead of Print.
-
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810 J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-26 Leonard J. Appleman, Se Eun Kim, Wayne B. Harris, Sumanta K. Pal, Michael R. Pins, Jill Kolesar, Neeraj Agarwal, Rahul A. Parikh, Daniel A. Vaena, Christopher W. Ryan, Mehmood Hashmi, Brian A. Costello, David Cella, Janice P. Dutcher, Robert S. DiPaola, Naomi B. Haas, Lynne I. Wagner, Michael A. Carducci
Journal of Clinical Oncology, Ahead of Print.
-
Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-20 James B. Yu, David M. DeStephano, Brian Jeffers, David P. Horowitz, Pamela R. Soulos, Cary P. Gross, Simon K. Cheng
Journal of Clinical Oncology, Ahead of Print.
-
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-19 John D. Gordan, Erin B. Kennedy, Ghassan K. Abou-Alfa, Eliza Beal, Richard S. Finn, Terence P. Gade, Laura Goff, Shilpi Gupta, Jennifer Guy, Hang T. Hoang, Renuka Iyer, Ishmael Jaiyesimi, Minaxi Jhawer, Asha Karippot, Ahmed O. Kaseb, R. Kate Kelley, Jeremy Kortmansky, Andrea Leaf, William M. Remak, Davendra P.S. Sohal, Tamar H. Taddei, Andrea Wilson Woods, Mark Yarchoan, Michal G. Rose
Journal of Clinical Oncology, Ahead of Print.
-
Shared Care Is an Appropriate Model for Many Cancer Survivors J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-18 Michael Jefford, Raymond J. Chan, Jon D. Emery
Journal of Clinical Oncology, Ahead of Print.
-
Internal Mammary Node Irradiation Debate: Case Closed? Not Yet, and Maybe Never J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-18 Abram Recht
Journal of Clinical Oncology, Ahead of Print.
-
Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer—We Must Do Better J. Clin. Oncol. (IF 45.3) Pub Date : 2024-03-15 Winta T. Mehtsun, Samir Gupta
Journal of Clinical Oncology, Ahead of Print.
-
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Shannon N. Westin, Kathleen Moore, Hye Sook Chon, Jung-Yun Lee, Jessica Thomes Pepin, Michael Sundborg, Ayelet Shai, Joseph de la Garza, Shin Nishio, Michael A. Gold, Ke Wang, Kristi McIntyre, Todd D. Tillmanns, Stephanie V. Blank, Ji-Hong Liu, Michael McCollum, Fernando Contreras Mejia, Tadaaki Nishikawa, Kathryn Pennington, Zoltan Novak, Andreia Cristina De Melo, Jalid Sehouli, Dagmara Klasa-Mazurkiewicz
Journal of Clinical Oncology, Ahead of Print.
-
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301 J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang, Ross A. Soo, Thanyanan Reungwetwattana, James Chih-Hsin Yang, Irfan Cicin, Dong-Wan Kim, Yi-Long Wu, Shun Lu, Ki Hyeong Lee, Yong-Kek Pang, Anastasia Zimina, Chin Heng Fong, Elena Poddubskaya, Ahmet Sezer, Soon Hin How, Pongwut Danchaivijitr, YuKyung Kim, Yeji Lim, Taewon An, Hana Lee, Hae Mi Byun, Bojan Zaric
Journal of Clinical Oncology, Ahead of Print.
-
Restoration of Quality of Life and Functional Recovery After Colorectal Cancer Surgery in Older Adults J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Anthony Loria, Fergal J. Fleming
Journal of Clinical Oncology, Ahead of Print.
-
Improving Report of ADAURA Trial by Distinguishing Treatment-Related Adverse Events From Treatment-Emergent Adverse Events and Assessing Independence of Censoring in Final Disease-Free Survival Analyses J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Danna Wu, Guo-Fu Li
Journal of Clinical Oncology, Ahead of Print.
-
Assessing the Ability of Long Noncoding RNA Expression to Predict Patient Outcomes in Pediatric AML J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Zachary R. McCaw, Paul G. Richardson, Lee-Jen Wei
Journal of Clinical Oncology, Ahead of Print.
-
Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Isacco Montroni, Giampaolo Ugolini, Nicole M. Saur, Siri Rostoft, Antonino Spinelli, Barbara L. Van Leeuwen, Nicola De Liguori Carino, Federico Ghignone, Michael T. Jaklitsch, Jakub Kenig, Anna Garutti, Chiara Zingaretti, Flavia Foca, Bernadette Vertogen, Oriana Nanni, Steven D. Wexner, Riccardo A. Audisio
Journal of Clinical Oncology, Ahead of Print.
-
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Michael L. Wang, Wojciech Jurczak, Pier Luigi Zinzani, Toby A. Eyre, Chan Y. Cheah, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, James N. Gerson, Ian Flinn, Benoit Tessoulin, Alvaro J. Alencar, Shuo Ma, David Lewis, Ewa Lech-Maranda, Joanna Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S. Tam, Talha Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar,
Journal of Clinical Oncology, Ahead of Print.
-
Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Tanios S. Bekaii-Saab, Rona Yaeger, Alexander I. Spira, Meredith S. Pelster, Joshua K. Sabari, Navid Hafez, Minal Barve, Karen Velastegui, Xiaohong Yan, Aditya Shetty, Hirak Der-Torossian, Shubham Pant
Journal of Clinical Oncology, Ahead of Print.
-
You Get (offered) What You (can) Pay for: Explaining Disparities in End-of-Life Cancer Care J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Holly G. Prigerson, Alfred I. Neugut
Journal of Clinical Oncology, Ahead of Print.
-
End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Maureen Canavan, Xiaoliang Wang, Mustafa Ascha, Rebecca Miksad, Timothy N. Showalter, Gregory Calip, Cary P. Gross, Kerin Adelson
Journal of Clinical Oncology, Ahead of Print.
-
Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Yiwen Ling, Li Xuan, Na Xu, Fen Huang, Zhiping Fan, Ziwen Guo, Xiaojun Xu, Hui Liu, Ren Lin, Sijian Yu, Haiyan Zhang, Hua Jin, Meiqing Wu, Can Liu, Xinquan Liang, Ruiming Ou, Yuping Zhang, Xiaodan Liu, Hong Qu, Xiao Zhai, Jing Sun, Ying Zhao, Qifa Liu
Journal of Clinical Oncology, Ahead of Print.
-
Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Reinhard Ruppert, Theodor Junginger, Rainer Kube, Joachim Strassburg, Andreas Lewin, Joerg Baral, Christoph A. Maurer, Joerg Sauer, Johannes Lauscher, Guenther Winde, Rena Thomasmeyer, Sigmar Stelzner, Cornelius Bambauer, Soenke Scheunemann, Axel Faedrich, Daniel Wollschlaeger, Susanne Merkel
Journal of Clinical Oncology, Ahead of Print.
-
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Constantin Roder, Walter Stummer, Jan Coburger, Moritz Scherer, Patrick Haas, Christian von der Brelie, Marcel Alexander Kamp, Mario Löhr, Christina A. Hamisch, Marco Skardelly, Torben Scholz, Stephanie Schipmann, Julian Rathert, Catrin Marlene Brand, Andrej Pala, Ulrike Ernemann, Florian Stockhammer, Rüdiger Gerlach, Paul Kremer, Roland Goldbrunner, Ralf-Ingo Ernestus, Michael Sabel, Veit Rohde, Ghazaleh
Journal of Clinical Oncology, Ahead of Print.
-
Tradeoffs of Proceeding to Resection Rather Than Mediastinoscopy After Negative Endosonography J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Farhood Farjah
Journal of Clinical Oncology, Ahead of Print.
-
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Martin F. Kaiser, Andrew Hall, Katrina Walker, Amy Sherborne, Ruth M. De Tute, Nicola Newnham, Sadie Roberts, Emma Ingleson, Kristian Bowles, Mamta Garg, Anand Lokare, Christina Messiou, Richard S. Houlston, Graham Jackson, Gordon Cook, Guy Pratt, Roger G. Owen, Mark T. Drayson, Sarah R. Brown, Matthew W. Jenner
Journal of Clinical Oncology, Ahead of Print.
-
Sex and Tumor-Site Differences in the Association of Alcohol Intake With the Risk of Early-Onset Colorectal Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Eun Hyo Jin, Kyungdo Han, Cheol Min Shin, Dong Ho Lee, Seung Joo Kang, Joo Hyun Lim, Yoon Jin Choi
Journal of Clinical Oncology, Ahead of Print.
-
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Jeff M. Michalski, Kathryn A. Winter, Bradley R. Prestidge, Martin G. Sanda, Mahul Amin, William S. Bice, Hiram A. Gay, Geoffrey S. Ibbott, Juanita M. Crook, Charles N. Catton, Adam Raben, Walter Bosch, David C. Beyer, Steven J. Frank, Michael A. Papagikos, Seth A. Rosenthal, H. Joseph Barthold, Mack Roach, Jennifer Moughan, Howard M. Sandler
Journal of Clinical Oncology, Ahead of Print.
-
The CCDI Comes Out of the Starting Block J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Kevin Shannon
Journal of Clinical Oncology, Ahead of Print.
-
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Laura K. Hilton, Henry S. Ngu, Brett Collinge, Kostiantyn Dreval, Susana Ben-Neriah, Christopher K. Rushton, Jasper C.H. Wong, Manuela Cruz, Andrew Roth, Merrill Boyle, Barbara Meissner, Graham W. Slack, Pedro Farinha, Jeffrey W. Craig, Alina S. Gerrie, Ciara L. Freeman, Diego Villa, Judith A. Rodrigo, Kevin Song, Michael Crump, Lois Shepherd, Annette E. Hay, John Kuruvilla, Kerry J. Savage, Robert
Journal of Clinical Oncology, Ahead of Print.
-
Rationale for Cotargeting Hepatocyte Growth Factor and Epidermal Growth Factor Receptor in Recurrent/Metastatic Head and Neck Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Stéphanie Kermorgant
Journal of Clinical Oncology, Ahead of Print.
-
Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Hannah M. Seagle, Samantha R. Keller, Sean V. Tavtigian, Carolyn Horton, Andreana N. Holowatyj
Journal of Clinical Oncology, Ahead of Print.
-
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01 J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Toshio Shimizu, Jacob Sands, Kiyotaka Yoh, Alexander Spira, Edward B. Garon, Satoru Kitazono, Melissa L. Johnson, Funda Meric-Bernstam, Anthony W. Tolcher, Noboru Yamamoto, Jon Greenberg, Yui Kawasaki, Hong Zebger-Gong, Fumiaki Kobayashi, Penny Phillips, Aaron E. Lisberg, Rebecca S. Heist
Journal of Clinical Oncology, Ahead of Print.
-
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRASG12C–Mutated Non–Small-Cell Lung Cancer Who Have Untreated CNS Metastases J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Marcelo V. Negrao, Alexander I. Spira, Rebecca S. Heist, Pasi A. Jänne, Jose M. Pacheco, Jared Weiss, Shirish M. Gadgeel, Karen Velastegui, Wenjing Yang, Hirak Der-Torossian, James G. Christensen, Joshua K. Sabari
Journal of Clinical Oncology, Ahead of Print.
-
JCO Flashback: Predictive Value of KRAS Mutations on the Outcomes of Panitumumab Monotherapy in Colorectal Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2023
Journal of Clinical Oncology, Volume 41, Issue 18, Page 3277-3277, June 2023.
-
Flashback Foreword: KRAS Is a Selection Marker for Panitumumab Benefit in Patients With Metastatic Colorectal Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Andrew H. Ko
Journal of Clinical Oncology, Volume 41, Issue 18, Page 3275-3276, June 2023.
-
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Antonio C. Wolff, Mark R. Somerfield, Mitchell Dowsett, M. Elizabeth H. Hammond, Daniel F. Hayes, Lisa M. McShane, Thomas J. Saphner, Patricia A. Spears, Kimberly H. Allison
Journal of Clinical Oncology, Ahead of Print.
-
Encorafenib and Binimetinib: A New Treatment Option for BRAFV600E-Mutant Non–Small-Cell Lung Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Thomas E. Stinchcombe
Journal of Clinical Oncology, Ahead of Print.
-
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048) J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Ethan Basch, Amylou C. Dueck, Sandra A. Mitchell, Harvey Mamon, Martin Weiser, Leonard Saltz, Marc Gollub, Lauren Rogak, Brenda Ginos, Gina L. Mazza, Brian Colgrove, George Chang, Lori Minasian, Andrea Denicoff, Gita Thanarajasingam, Benjamin Musher, Thomas George, Alan Venook, Jeffrey Farma, Eileen O'Reilly, Jeffrey A. Meyerhardt, Qian Shi, Deborah Schrag
Journal of Clinical Oncology, Ahead of Print.
-
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Gregory J. Riely, Egbert F. Smit, Myung-Ju Ahn, Enriqueta Felip, Suresh S. Ramalingam, Anne Tsao, Melissa Johnson, Francesco Gelsomino, Raymond Esper, Ernest Nadal, Michael Offin, Mariano Provencio, Jeffrey Clarke, Maen Hussain, Gregory A. Otterson, Ibiayi Dagogo-Jack, Jonathan W. Goldman, Daniel Morgensztern, Ann Alcasid, Tiziana Usari, Paul Wissel, Keith Wilner, Nuzhat Pathan, Svitlana Tonkovyd,
Journal of Clinical Oncology, Ahead of Print.
-
Use of Large Language Models and Artificial Intelligence Tools in Works Submitted to Journal of Clinical Oncology J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Kathy Miller, Emilie Gunn, Angela Cochran, Hal Burstein, Jonathan Friedberg, Stephanie Wheeler, Paul Frankel
Journal of Clinical Oncology, Ahead of Print.
-
Reply to M.C. Strach et al J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Michael B. Foote, Garrett M. Nash, Andrea Cercek
Journal of Clinical Oncology, Ahead of Print.
-
Genomic Subtypes of Appendiceal Adenocarcinoma: Enough to Guide Clinical Decision Making? J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Madeleine C. Strach, Kate Mahon, Jorge Barriuso
Journal of Clinical Oncology, Ahead of Print.
-
Flashback Foreword: Bevacizumab + Carboplatin/Paclitaxel in NSCLC. J. Clin. Oncol. (IF 45.3) Pub Date : 2023-05-01 Thomas E Stinchcombe
-
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer? J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Ian F. Tannock, Daniel A. Goldstein, Jonathan Ofer, Bishal Gyawali, Tomer Meirson
Journal of Clinical Oncology, Ahead of Print.
-
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy. J. Clin. Oncol. (IF 45.3) Pub Date : 2023-03-13 Siamak Daneshmand,Clint Cary,Timothy Masterson,Lawrence Einhorn,Nabil Adra,Stephen A Boorjian,Christian Kollmannsberger,Anne Schuckman,Alan So,Peter Black,Aditya Bagrodia,Eila Skinner,Mehrdad Alemozaffar,Timothy Brand,Scott Eggener,Phillip Pierorazio,Kelly Stratton,Lucia Nappi,Craig Nichols,Chunqiao Luo,Ming Li,Brian Hu
PURPOSE The long-term toxicities of chemotherapy and radiotherapy can represent a significant burden to testicular cancer survivors. Retroperitoneal lymph node dissection (RPLND) is an established treatment for testicular germ cell tumors with minimal late morbidity although little data exist on its efficacy in early metastatic seminoma. Surgery in early metastatic seminoma is a prospective phase II
-
DPYD Testing: Time to Put Patient Safety First J. Clin. Oncol. (IF 45.3) Pub Date : 2023 Sharyn D. Baker, Susan E. Bates, Gabriel A. Brooks, William L. Dahut, Robert B. Diasio, Wafik S. El-Deiry, William E. Evans, William D. Figg, Dan L. Hertz, J. Kevin Hicks, Suneel Kamath, Pashtoon Murtaza Kasi, Todd C. Knepper, Howard L. McLeod, Peter H. O'Donnell, Mary V. Relling, Michelle A. Rudek, Tristan M. Sissung, D. Max Smith, Alex Sparreboom, Sandra M. Swain, Christine M. Walko
Journal of Clinical Oncology, Ahead of Print.